Xylan-regulated delivery of human keratinocyte growth factor-2 to the inflamed colon by the human anaerobic commensal bacterium Bacteroides ovatus

Gut

Volumn 59, Issue 4, 2010, Pages 461-469

  Hamady, Zaed Z R ^a   Scott, Nigel ^b   Farrar, Mark D ^a   Lodge, J Peter A ^a   Holland, Keith T ^a   Whitehead, Terence ^c   Carding, Simon R ^a,d  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^c NATIONAL CENTER FOR AGRICULTURAL UTILIZATION RESEARCH   (United States)

^d UNIVERSITY OF EAST ANGLIA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; DEXTRAN SULFATE; FIBROBLAST GROWTH FACTOR 10; XYLAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL STRAIN; BACTEROIDES OVATUS; BIOSAFETY; COLITIS; COLON MUCOSA; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG DELIVERY SYSTEM; GOBLET CELL; INTESTINE EPITHELIUM; MALE; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; RECTUM HEMORRHAGE; WEIGHT REDUCTION;

ANIMALS; BACTEROIDES; BIOLOGICAL ASSAY; CELL PROLIFERATION; COLITIS; DEXTRAN SULFATE; DISEASE MODELS, ANIMAL; DRUG DELIVERY SYSTEMS; ENDO-1,4-BETA XYLANASES; FIBROBLAST GROWTH FACTOR 10; GENETIC ENGINEERING; INTESTINAL MUCOSA; MALE; MICE; MICE, INBRED C57BL; MUCINS; PROMOTER REGIONS, GENETIC; XYLANS;

EID: 77950799444     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gut.2008.176131     Document Type: Article

References (32)

1. Werner S. Keratinocyte growth factor: a unique player in epithelial repair processes. Cytokine Growth Factor Rev 1998;9:153-165 (Pubitemid 28376451)
2. Baumgart DC, Sandborn WJ. Inflammatory bowel disease: clinical aspects and established and evolving therapies. Lancet 2007;369:1641-1657 (Pubitemid 46722637)
3. Dignass A. Mechanisms and modulation of intestinal epithelial repair. Inflamm Bowel Dis 2001;7:68-77. (Pubitemid 32492639)
4. Loftus EV. Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology 2004;126:1504-1517 (Pubitemid 38649869)
5. Han DS, Li F, Holt L, et al. Keratinocyte growth factor-2 (FGF-10) promotes healing of experimental small intestinal ulceration in rats. Am J Physiol Gastrointest Liver Physiol 2000;279:G1011-22.
6. Zeeh JM, Procaccino F, Hoffmann P, et al. Keratinocyte growth factor ameliorates mucosal injury in an experimental model of colitis in rats. Gastroenterology 1996;110:1077-1083 (Pubitemid 26113747)
7. Miceli R, Hubert M, Santiago G, et al. Efficacy of keratinocyte growth factor-2 in dextran sulfate sodium-induced murine colitis. J Pharmacol Exp Ther 1999;290:464-471 (Pubitemid 29302357)
8. Dorr W, Bassler S, Reichel S, et al. Reduction of radiochemotherapy- induced early oral mucositis by recombinant human keratinocyte growth factor (palifermin): Experimental studies in mice. Int J Radiat Oncol Biol Phys 2005;62:881-887 (Pubitemid 40779782)
9. Farrell CL, Rex KL, Chen JN, et al. The effects of keratinocyte growth factor in preclinical models of mucositis. Cell Prolif 2002;35:78-85. (Pubitemid 34985150)
10. Sandborn WJ, Sands BE, Wolf DC, et al. Repifermin (keratinocyte growth factor-2) for the treatment of active ulcerative colitis: a randomized, double-blind, placebo-controlled, dose-escalation trial. Aliment Pharmacol Ther 2003;17:1355-1364
11. Steidler L, Hans W, Schotte L, et al. Treatment of murine colitis by Lactococcus lactis secreting interleukin-10. Science 2000;289:1352-1355 (Pubitemid 30656052)
12. Salyers AA, Gherardini F, O'Brien M. Utilization of xylan by two species of human colonic Bacteroides. Appl Environ Microbiol 1981;41:1065-1068 (Pubitemid 11127241)
13. Whitehead TR, Hespell RB. The genes for three xylan-degrading activities from Bacteroides ovatus are clustered in a 3.8-kilobase region. J Bacteriol 1990;172:2408-2412
14. Croucher SC, Houston AP, Bayliss CE, et al. Bacterial populations associated with different regions of the human colon wall. Appl Environ Microbiol 1983;45:1025-1033
15. Hamady ZZR, Farrar M, Whitehead RH, et al. Identification and use of the putative Bacteroides ovatus xylanase promoter for the inducible production of recombinant human proteins. Microbiology 2008;154:3165-3174
16. Erdman SH, Christensen RD, Bradley PP, et al. Supply and release of storage neutrophils. A developmental study. Biol Neonate 1982;41:132-137
17. Shoucheng N, Chaoxiang S, Khan WB, et al. Effects of keratinocyte growth factor on the proliferation and radiation survival of human squamous cell carcinoma cell lines in vitro and in vivo. Int J Radiat Oncol Biol Phys 1998;40:177-187
18. Tancula E, Feldhaus MJ, Bedzyk LA, et al. Location and characterization of genes involved in binding of starch to the surface of Bacteroides thetaiotaomicron. J Bacteriol 1992;174:5609-5616
19. Steidler L, Neirynck S, Huyghebaert N, et al. Biological containment of genetically modified Lactococcus lactis for intestinal delivery of human interleukin 10. Nat Biotechnol 2003;21:785-789 (Pubitemid 36791397)
20. Jurjus AR, Khoury NN, Reimund J-M. Animal models of inflammatory bowel disease. J Pharmacol Toxicol Methods 2004;50:81-92. (Pubitemid 39286320)
21. Dieleman LA, Ridwan BU, Tennyson GS, et al. Dextran sulfate sodium-induced colitis occurs in severe combined immunodeficient mice. Gastroenterology 1994;107:1643-1652
22. Hudcovic T, Kozakova H, Kolinska J, et al. Monocolonization with Bacteroides ovatus protects immunodeficient SCID mice from mortality in chronic intestinal inflammation caused by long-lasting dextran sodium sulphate treatment. Physiol Res 2008;58:101-110
23. Okayasu I, Hatakeyama S, Yamada M, et al. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 1990;98:694-702. (Pubitemid 20069706)
24. Taupin D, Podolsky DK. Trefoil factors: initiators of mucosal healing. Nat Rev Mol Cell Biol 2003;4:721-732 (Pubitemid 37082187)
25. Telega GW, Baumgart DC, Carding SR. Uptake and presentation of antigen to T cells by primary colonic epithelial cells in normal and diseased states. Gastroenterology 2000;119:1548-1559
26. Visco V, Belleudi F, Marchese C, et al. Differential response to keratinocyte growth factor receptor and epidermal growth factor receptor ligands of proliferating and differentiating intestinal epithelial cells. J Cell Physiol 2004;200:31-44. (Pubitemid 38720619)
27. Saitoh S, Noda S, Aiba Y, et al. Bacteroides ovatus as the predominant commensal intestinal microbe causing a systemic antibody response in inflammatory bowel disease. Clin Diagn Lab Immunol 2002;9:54-59 (Pubitemid 34084275)
28. Moure A, Gullón P, Domínguez H, et al. Advances in the manufacture, purification and applications of xylo-oligosaccharides as food additives and neutraceuticals. Process Biochem 2006;41:1913-1923 (Pubitemid 44160558)
29. Braat H, Rottiers P, Hommes DW, et al. A phase I trial with transgenic bacteria expressing interleukin-10 in Crohn's disease. Clin Gastroenterol Hepatol 2006;4:754-759 (Pubitemid 43841860)
30. Singh JCI, Cruickshank SM, Newton DJ, et al. Toll-like receptor-mediated responses of primary intestinal epithelial cells during the development of colitis. Am J Physiol Gastrointest Liver Physiol 2005;288:G514-24.
31. Hausmann M, Kiessling S, Mestermann S, et al. Toll-like receptors 2 and 4 are upregulated during intestinal inflammation. Gastroenterology 2002;122:1987-2000. (Pubitemid 34651441)
32. Wiercińska-Drapało A, Flisiak R, Prokopowicz D. Effect of ulcerative colitis activity on plasma concentration of transforming growth factor beta1. Cytokine 2001;14:343-346 (Pubitemid 32730475)